Email ID
Password
Scrip   
Eisai looks to its acquisitions for growth
10 March 2009
Ian Haydock

Eisai expects its US sales to reach $4 billion in fiscal 2009 (beginning April 1st), two years ahead of its original plan and boosted by the acquisition of the oncology company MGI Pharma.

The main contributor to the business will continue to be Aricept (donepezil) for Alzheimer's disease,...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36